Phase II study of weekly 4'-epidoxorubicin in patients with metastatic adenocarcinoma of the cervix: an EORTC Gyneological Cancer Cooperative Group Study

MEL Burg; G Bolis; BJM Bakker; D Curran; T Sahmoud; JB Vermorken

doi:10.1016/S0959-8049(97)00172-X

Phase II study of weekly 4'-epidoxorubicin in patients with metastatic adenocarcinoma of the cervix: an EORTC Gyneological Cancer Cooperative Group Study

MEL Burg
, G Bolis
, BJM Bakker
, D Curran
, T Sahmoud
, JB Vermorken

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

42 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	1513-1515
Number of pages	3
Journal	European Journal of Cancer
Volume	33
Issue number	9
DOIs	https://doi.org/10.1016/S0959-8049(97)00172-X
Publication status	Published - 1997

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC 04-01-DD-08-01

Access to Document

10.1016/S0959-8049(97)00172-X

REPUB_55528.pdfFinal published version, 305 KB

http://hdl.handle.net/1765/55528

Cite this

@article{4fb3055000024f4e836cc904ad5e3320,

title = "Phase II study of weekly 4'-epidoxorubicin in patients with metastatic adenocarcinoma of the cervix: an EORTC Gyneological Cancer Cooperative Group Study",

author = "MEL Burg and G Bolis and BJM Bakker and D Curran and T Sahmoud and JB Vermorken",

year = "1997",

doi = "10.1016/S0959-8049(97)00172-X",

language = "Undefined/Unknown",

volume = "33",

pages = "1513--1515",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

number = "9",

}

TY - JOUR

T1 - Phase II study of weekly 4'-epidoxorubicin in patients with metastatic adenocarcinoma of the cervix: an EORTC Gyneological Cancer Cooperative Group Study

AU - Burg, MEL

AU - Bolis, G

AU - Bakker, BJM

AU - Curran, D

AU - Sahmoud, T

AU - Vermorken, JB

PY - 1997

Y1 - 1997

U2 - 10.1016/S0959-8049(97)00172-X

DO - 10.1016/S0959-8049(97)00172-X

M3 - Article

SN - 0959-8049

VL - 33

SP - 1513

EP - 1515

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 9

ER -